Optimizing Outcomes With Oral Antiplatelet Therapies
|
|
|
-
Optimizing Outcomes With Oral Antiplatelet Therapies
Online presentation and downloadable slides covering key concepts in selecting oral antiplatelet therapies.
-
In my approach to antiplatelet therapy for patients with PAD, I maximize available data and draw from coronary guidelines when necessary.
-
In this interactive presentation, Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC, reviews current guidelines and emerging data on selecting oral antiplatelet therapies, including the optimal duration of dual antiplatelet therapy in selected patients.
Latest Content
-
| Christopher P. Cannon MD - 1/22/2016 |
3 comments / Last Comment: 8/26/2016 |
Results from a recent subanalysis of the DAPT study have the potential to help clinicians address the challenging question of whether to extend DAPT duration for patients with coronary stents.
-
| Joshua A. Beckman MD - 12/9/2015 |
6 comments / Last Comment: 8/26/2016 |
In my approach to antiplatelet therapy for patients with PAD, I maximize available data and draw from coronary guidelines when necessary.
-
In this downloadable slideset, Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC, reviews current guidelines and emerging data on selecting oral antiplatelet therapies, including the optimal duration of dual antiplatelet therapy in selected patients.
Date Posted: 10/2/2015
-
In this interactive presentation, Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC, reviews current guidelines and emerging data on selecting oral antiplatelet therapies, including the optimal duration of dual antiplatelet therapy in selected patients.
Faculty: Deepak L. Bhatt MD, MPH, FACC, FAHA, FSCAI, FESC
Released: 10/2/2015
|
|
|